Skip to content
Disclosery

EXANE DERIVATIVES: UBS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on UBS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 22,455 UBS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 22,455 shares
    Change vs previous 13F -21,925 shares

    0.21% of the 13F portfolio, value $360,411.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 44,380 shares
    Change vs previous 13F -268,874 shares

    0.25% of the 13F portfolio, value $870,774.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 313,254 shares
    Change vs previous 13F -1,333,733 shares

    1.37% of the 13F portfolio, value $5,639,768.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,646,987 shares
    Change vs previous 13F +460,858 shares

    6.59% of the 13F portfolio, value $26,415,918.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,186,129 shares
    Change vs previous 13F +976,648 shares

    4.15% of the 13F portfolio, value $17,678,736.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 209,481 shares
    Change vs previous 13F -189,428 shares

    0.98% of the 13F portfolio, value $3,247,689.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 398,909 shares
    Change vs previous 13F -415,488 shares

    1.71% of the 13F portfolio, value $5,651,909.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 814,397 shares
    Change vs previous 13F not available

    2.96% of the 13F portfolio, value $9,091,548.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).